NoesisPharma

Phoenix, Arizona 85032

0 studies enrolling now · 10 studies all time

What they study most

Chronic Lower Back Pain, Chronic Pain, Depressive Disorder, Major, Fibromyalgia, Major Depressive Disorder, PTSD

Studies at this site

• Open Label Extension Safety and Efficacy Study of TNX-102 SL Tablets in Military Related PTSD and Related Conditions — Completed
• Safety and Efficacy Study of TNX-102 SL in Subjects With Military-Related PTSD and Related Conditions — Completed
• Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain — Completed
• Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD) — Completed
• Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD — Completed
• Study of Adjunctive or Monotherapy Rapastinel Treatment in Patients With Major Depressive Disorder (MDD) — Stopped early
• Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder — Completed
• A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder — Completed
• A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03) — Completed
• A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome — Completed